Anavex Life Sciences Corp.
Anavex Life Sciences Corp. (AVXL) — Form 8-K: Current report
About this filing
Anavex Life Sciences Corp. (AVXL) filed an 8-K on Nov 3, 2026 reporting an executive or director change or pay arrangement (Item 5.02), with exhibits (Item 9.01).
Key facts
- Item 5.02 · Executive or director change or pay arrangement
- Item 9.01 · Financial statements and exhibits
More AVXL filings
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 8-K
Filed Nov 2, 2026
- 8-K
Filed Oct 20, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.